Japanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHL

NCT02342665 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma Non-Hodgkin

Interventions

DRUG: Copanlisib (BAY80-6946)

Sponsor

Bayer